Pfizer CEO Sold $5.6m Worth Of Stocks On Day Of Vaccine Announcement
Bourla sold 132,508 shares at an average price of $41.94 per share, or nearly $5.6 million, according to a
The sale was part of a pre-scheduled agreement set-up in August.
The company said: “The sale of these shares is part of Dr Bourla’s personal financial planning and a
A spokesman added: “After being with the company for more than 25 years, Albert owns a substantial amount of
“He now holds approximately nine times his salary in Pfizer stock after the sale this week.”
Pfizer had previously rejected taking part in Operation Warp Speed drug development program and used $2bn
The vaccine could generate nearly $13bn in global sales next year, according to analysts at Morgan Stanley,